Ask AI
ProCE Banner Activity

The Add-On Advantage: Precision Adjunctive Care in MDD

Slideset

This downloadable slideset reviews adjunctive therapy for MDD in adults with persistent residual symptoms after antidepressant treatment. Topics include when to switch vs add on therapy, individualized treatment selection, safety, and dosing considerations for approved and emerging adjunctive options.

Released: May 07, 2026

Share

Partners

Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Target Audience

This program is intended for physicians, physician associates, nurse practitioners, registered nurses, pharmacists, social workers, and psychologists engaged in the care of patients with major depressive disorder.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Assess optimal timing and clinical rationale for switching or augmenting treatment in patients with MDD

  • Evaluate the pharmacologic profiles, efficacy, and safety of approved adjunctive therapies for adults with MDD that improve residual symptoms, including anhedonia and cognitive impairment

  • Apply current guideline-based and evidence-based strategies to optimize dosing and titration of adjunctive therapies for adults with MDD who exhibit residual symptoms